(+)-2-Decanol

右旋莰醇

Report date: 2025/07/24 16:27:29
NME

Base Information

Drug Name(+)-2-Decanol
Drug Alias Name(+)-decanol(+)-2-Camphanol(+)-2-decanol+ 2-borneol
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor necrosis factor α inhibitorsInterleukin-1 beta inhibitorsCyclooxygenase-2 inhibitors +[4] 
TargetsTumor necrosis factor αInterleukin-1 betaCyclooxygenase-2 +[4] 
Therapy Area/IndicationsIschemic StrokePainFever
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesJiangsu Simcere Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesJiangsu Simcere Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsIschemic StrokePainFever
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A